North America continues to lead the global sclerotherapy market, accounting for a substantial share of worldwide revenue. The region's dominance stems from a combination of advanced healthcare infrastructure, high awareness levels regarding venous disorders, and supportive regulatory frameworks that encourage innovation. As the demand for minimally invasive vein treatments continues to rise...